 |
|
Effects of Omega-3 Fatty Acids on Cancer Risk
A Systematic Review
Catherine H. MacLean, MD, PhD;
Sydne J. Newberry, PhD;
Walter A. Mojica, MD, MPH;
Puja Khanna, MD;
Amalia M. Issa, MPH, PhD;
Marika J. Suttorp, MS;
Yee-Wee Lim, MD, PhD;
Shana B. Traina, MA;
Lara Hilton, BA;
Rena Garland, BA;
Sally C. Morton, PhD
JAMA. 2006;295:403-415.
Context Omega-3 fatty acids are purported to reduce the risk of cancer. Studies have reported mixed results.
Objective To synthesize published and unpublished evidence to determine estimates of the effect of omega-3 fatty acids on cancer risk in prospective cohort studies.
Data Sources Articles published from 1966 to October 2005 identified through MEDLINE, PREMEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and CAB Health; unpublished literature sought through letters to experts in the neutraceutical industry.
Study Selection A total of 38 articles with a description of effects of consumption of omega-3 fatty acids on tumor incidence, prospective cohort study design, human study population; and description of effect of omega-3 among groups with different levels of exposure in the cohort were included. Two reviewers independently reviewed articles using structured abstraction forms; disagreements were resolved by consensus.
Data Extraction Two reviewers independently abstracted detailed data about the incidence of cancer, the type of cancer, the number and characteristics of the patients, details on the exposure to omega-3 fatty acids, and the elapsed time between the intervention and outcome measurements. Data about the methodological quality of the study were also abstracted.
Data Synthesis Across 20 cohorts from 7 countries for 11 different types of cancer and using up to 6 different ways to categorize omega-3 fatty acid consumption, 65 estimates of the association between omega-3 fatty acid consumption were reported. Among these, only 8 were statistically significant. The high degree of heterogeneity across these studies precluded pooling of data. For breast cancer 1 significant estimate was for increased risk (incidence risk ratio [IRR], 1.47; 95% confidence interval [CI], 1.10-1.98) and 3 were for decreased risk (RR, 0.68-0.72); 7 other estimates did not show a significant association. For colorectal cancer, there was 1 estimate of decreased risk (RR, 0.49; 95% CI, 0.27-0.89) and 17 estimates without association. For lung cancer one of the significant associations was for increased cancer risk (IRR, 3.0; 95% CI, 1.2-7.3), the other was for decreased risk (RR, 0.32; 95% CI, 0.13-0.76), and 4 other estimates were not significant. For prostate cancer, there was 1 estimate of decreased risk (RR, 0.43; 95% CI, 0.22-0.83) and 1 of increased risk (RR, 1.98; 95% CI, 1.34-2.93) for advanced prostate cancer; 15 other estimates did not show a significant association. The study that assessed skin cancer found an increased risk (RR, 1.13; 95% CI, 1.01-1.27). No significant associations between omega-3 fatty acid consumption and cancer incidence were found for aerodigestive cancer, bladder cancer, lymphoma, ovarian cancer, pancreatic cancer, or stomach cancer.
Conclusions A large body of literature spanning numerous cohorts from many countries and with different demographic characteristics does not provide evidence to suggest a significant association between omega-3 fatty acids and cancer incidence. Dietary supplementation with omega-3 fatty acids is unlikely to prevent cancer.
Author Affiliations: Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica (Drs MacLean, Newberry, Mojica, Lim, and Morton and Mss Suttorp, Hilton, and Garland), the Greater Los Angeles VA Healthcare System, Los Angeles (Dr MacLean), and the University of California Los Angeles School of Public Health, Los Angeles (Dr Issa and Ms Traina); and Wright State University School of Medicine, Dayton, Ohio (Dr Khanna).
RELATED LETTERS
Omega-3 Fatty Acids and Cancer Risk
Yong Q. Chen, Isabelle M. Berquin, Larry W. Daniel, Iris J. Edwards, Joseph T. O’Flaherty, Mike J. Thomas, Janet A. Tooze, and Bob Wykle
JAMA. 2006;296(3):282.
EXTRACT
| FULL TEXT
Omega-3 Fatty Acids and Cancer Risk—Reply
Catherine H. MacLean and Sydne J. Newberry
JAMA. 2006;296(3):282.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Fish, human health and marine ecosystem health: policies in collision
Brunner et al.
Int J Epidemiol 2008;0:dyn157v1-dyn157.
ABSTRACT
| FULL TEXT
A 22-year Prospective Study of Fish, n-3 Fatty Acid Intake, and Colorectal Cancer Risk in Men
Hall et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1136-1143.
ABSTRACT
| FULL TEXT
Gastric Cancer Risk and Erythrocyte Composition of Docosahexaenoic Acid with Anti-inflammatory Effects
Kuriki et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2406-2415.
ABSTRACT
| FULL TEXT
Prostate cancer prevention by nutritional means to alleviate metabolic syndrome
Barnard
Am. J. Clin. Nutr. 2007;86:889S-893S.
ABSTRACT
| FULL TEXT
Dietary Isoflavones May Protect against Prostate Cancer in Japanese Men
Nagata et al.
J. Nutr. 2007;137:1974-1979.
ABSTRACT
| FULL TEXT
Dietary Fatty Acids and Colorectal Cancer: A Case-Control Study
Theodoratou et al.
Am J Epidemiol 2007;166:181-195.
ABSTRACT
| FULL TEXT
A collaborative effort to apply the evidence-based review process to the field of nutrition: challenges, benefits, and lessons learned
Balk et al.
Am. J. Clin. Nutr. 2007;85:1448-1456.
ABSTRACT
| FULL TEXT
Docosahexaenoic Acid and Butyrate Synergistically Induce Colonocyte Apoptosis by Enhancing Mitochondrial Ca2+ Accumulation
Kolar et al.
Cancer Res. 2007;67:5561-5568.
ABSTRACT
| FULL TEXT
Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps
Poole et al.
Carcinogenesis 2007;28:1259-1263.
ABSTRACT
| FULL TEXT
Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China
Shannon et al.
Am. J. Clin. Nutr. 2007;85:1090-1097.
ABSTRACT
| FULL TEXT
(n-3) PUFA Alter Raft Lipid Composition and Decrease Epidermal Growth Factor Receptor Levels in Lipid Rafts of Human Breast Cancer Cells
Schley et al.
J. Nutr. 2007;137:548-553.
ABSTRACT
| FULL TEXT
Using Genetic Variation to Optimize Nutritional Preemption
Gillies and Krul
J. Nutr. 2007;137:270S-274S.
ABSTRACT
| FULL TEXT
Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation
Shaikh and Edidin
Am. J. Clin. Nutr. 2006;84:1277-1289.
ABSTRACT
| FULL TEXT
Fish intake, contaminants, and human health: evaluating the risks and the benefits.
Mozaffarian and Rimm
JAMA 2006;296:1885-1899.
ABSTRACT
| FULL TEXT
Long-term Fatty Fish Consumption and Renal Cell Carcinoma Incidence in Women
Wolk et al.
JAMA 2006;296:1371-1376.
ABSTRACT
| FULL TEXT
American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity
Kushi et al.
CA Cancer J Clin 2006;56:254-281.
ABSTRACT
| FULL TEXT
Omega-3 fatty acids and cancer risk.
Chen et al.
JAMA 2006;296:282-282.
FULL TEXT
Oily fish and omega 3 fat supplements
Brunner
BMJ 2006;332:739-740.
FULL TEXT
What's new in the other general journals
Tonks
BMJ 2006;332:289-290.
FULL TEXT
|
